Myristoyl lysophosphatidylcholine is a biomarker and potential therapeutic target for community-acquired pneumonia

There is no gold standard for evaluating the severity of community-acquired pneumonia (CAP), and it is still based on a score. This study aimed to use the metabolomics method to find promised biomarkers in assessing disease severity and potential therapeutic targets for CAP. The result found that th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nan, Wengang, Xiong, Fen, Zheng, Hong, Li, Chen, Lou, Cong, Lei, Xiong, Wu, Huizhen, Gao, Hongchang, Li, Yuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712772/
https://www.ncbi.nlm.nih.gov/pubmed/36459717
http://dx.doi.org/10.1016/j.redox.2022.102556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712772/
https://www.ncbi.nlm.nih.gov/pubmed/36459717
http://dx.doi.org/10.1016/j.redox.2022.102556

Ejemplares similares